Schedule 13G ownership disclosure

IMMUNOPRECISE ANTIBODIES LTD

Security class unavailable · CUSIP: 45257F200

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,317,819
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041885-24-000003
Form type
SC 13G
Filer
INGALLS & SNYDER LLC
CIK
CIK 1041885
Filed
Feb 27, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub